Advanced search
Publication Cover
International Journal of Hyperthermia Volume 17, 2001 - Issue 5
Submit an article Journal homepage
236
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Heat-induced p53-dependent signal transduction and its role in hyperthermic cancer therapy

K. Ohnishi, T. Ohnishi
Pages 415-427 | Published online: 09 Jul 2009

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent J, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumour suppression. Cell 1993; 75: 817-25.
  • Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in GI checkpoint control Cell 1995; 82: 675-84.
  • Kastan M, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh W, Plunkett B, Vogelstein B, Fornance A. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-97.
  • Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornance JA. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene 1996; 13: 2255-63.
  • Miyashita T, Reed JC. Tumor-suppressor p53 is a direct transcriptional activator of the human Box gene. Cell 1995; 80: 293-9.
  • Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E, Radinsky R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 Expression MoI Cell Biol 1995; 15: 3032-40.
  • Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A, Oren M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptpsis. EMBO J 1997; 16: 4384-92.
  • Barak Y, Oren M. Binding of a 95kD protein is correlated with wild-type p53 activity. EMBO J 1992; 11: 2115-21.
  • Lane D. p53, guardian of the genome. Nature 1992; 358: 15-16.
  • Wang X, Ohnishi T. p53-dependent signal tranduction induced by stress. J Radiat Res 1997; 38: 179-94.
  • Hollstein M, Sidransky D, Vogelstein B, Hallis CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
  • Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, Kimura N, Matsuo M, Mizusawa H, Tanaka N, Koyama H, Namba M, Kanamuru R, Kuroki T. Screening the p53 status of human cell lines using a yeast functional assay. MoI Carcinogenesis 1997; 19: 243-53.
  • Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-7.
  • Bargonetti J, Friedman PN, Kern SE, Vogelstein B, Prives C. Wild-type but not mutant p53 immunopurfied proteins bind to sequences adjacent to the SV40 origin of replication. Cell 1991; 65: 1083-91.
  • Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science 1991; 252: 1708-11.
  • Ohnishi T, Wang X, Ohnishi K, Matsumoto H, Takahashi A. p53-dependent induction of WAF1 by heat treatment in human glioblastoma cells. J Biol Chem 1996; 271: 14510-3.
  • Ohnishi K, Wang X, Takahashi A, Ohnishi T. Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. Exp Cell Res 1998; 238: 399-406.
  • Kern SK, Pietenpol JA, Thiagalingham S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992; 256: 827-30.
  • Takenaka I, Morin F, Seizinger BR, Kley N. Regulation of the sequence-specific DNA binding of p53 by protein kinase C and protein phosphatases. J Biol Chem 1995; 270: 5405-11.
  • Banin S, Moyal L, Sheih S, Taya Y, Andersen CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281: 1674-7.
  • Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281: 1677-9.
  • Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP, Lavin MF, ATM associates with and phosphorylates p53: mapping the region of interaction Nature Gen 1998; 20: 398-400.
  • Nakagawa K, Taya Y, Tamai K, Yamaizumi M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. MoI Cell Biol 1999; 19: 2828-34.
  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13: 152-7.
  • Ohnishi T, Komatsu K, Tauchi H, Wang X, Takahashi A, Ohnishi K, Shiba A, Matsumoto H. Heat-induced accumulation of p53 and hsp72 is suppressed in lung fibroblasts from SCID mice. Int J Radiat Biol 2000; 76: 711-6.
  • Harima Y, Harima K, Shitata N, Oka A, Ohnishi T, Tanaka Y. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. J Cancer Res Clin Oncol 1998; 124: 503-10.
  • Harima Y, Nagata K, Harima K, Oka A, Ostapenko V, Shikata N, Ohnishi T, Tanaka Y. Bax and Bc1-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIb cervical carcinoma. Cancer 2000; 88: 131-7.
  • Lotem J, Sachs L. Regulation by bc1-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemic cells. Cell Growth Diff 1993; 4: 41-7.
  • Lotem J, Sadism L. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bc1-2 dependent and independent pathways. Cell Growth Diff 1994; 5: 321-7.
  • McIlwrath AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrests and radiosensitivity of human tumour cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 1994; 54: 3718-22.
  • Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M, Rotter V. Mutant p53 protein expression interferes with p53-independent apoptotic pathways. Oncogene 1998; 16: 3269-77.
  • Brachman DG, Beckett M, Graves D, Haraf D, Yokes E, Weichselbaum RR. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 1993; 53: 3667-9.
  • Feudis PD, Debernardis D, Beccaglia P, Valent! M, Sire EG, Arzani D, Stanzione S, Parodi S, D'Incalci M, Russo P, Broggini M. CDDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br J Cancer 1997; 76: 474-9.
  • Ohtsubo T, Park HJ, Lyons JC, Ohnishi T, Song CW, Effect of acidic environment and p53 on apoptosis induction by hyperthermia. Int J Hyperthermia 2000; 16: 481-91.
  • O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace Jr AJ, Kohn KW. Characterization of the p53 tumour suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitoiy potency of 123 anticancer agents. Cancer Res 1997; 57: 4285-300.
  • Huang H, Li CY, Little JB. Abrogation of p53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation. Int J Radiat Biol 1996; 70: 151-60.
  • Ishizaki K, Mimaki S, Nishizawa K. Genetic instability of p53-deficient mouse cells. Leukemia Suppl 1997; 3: 334-6.
  • Matsumoto H, Takahashi A, Wang X, Ohnishi K, Ohnishi T. Transfection of p53-knockout mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. Int J Radiat Oncol Biol Phys 1997; 38: 1089-95.
  • Ota I, Ohnishi K, Takahashi A, Yane K, Kanata H, Miyahara H, Ohnishi T, Hosoi H. Transfaction with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma Int J Radiat Oncol Biol Phys 2000; 47: 495-501.
  • Stennicke HR, Salvesen GS. Properties of the caspases. Biochim Biophys Acta 1998; 1387: 17-31.
  • Fujita N, Tsuruo T. Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem Biophys Res Comm 1998; 246: 484-8.
  • Wang GH, Mitsui K, Kotliarova S, Yamashita A, Nagao Y, Tokuhiro S, Iwatsubo T, Kanazawa I, Nukina N. Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. Neuroreport 1999; 10: 2435-8.
  • Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 1999; 18: 2423-30.
  • Kaufmann SH, Desnoyer S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early martker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-85.
  • Fujita N, Tsuruo T. Involvement of Bc1-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem Biophys Res Comm 1998; 246: 484-8.
  • Zhan Q, Fan S, Bae I, Guillouff C, Liebermann DA, O'Connor PM, Fornace Jr AJ. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994; 9: 3743-51.
  • Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bc1-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-1805.
  • Wu GS, Kirn K, El-Deiry WS. KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death. Adv Exp Med Biol 2000; 465: 143-51.
  • Tatsuta T, Shiraishi A, Mountz JD. The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation. J Biol Chem 2000; 275: 14248-54.
  • Mcllroy D, Sakahira H, Talanian RV, Nagata S. Involvement of caspase 3-activated Dnase in interaucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene 1999; 18: 4401-8.
  • Seo YR, Smith ML, Han SS, Fairbairn DW, O'Neill KL, Ryu JC. Mild hyperthermiainduced apoptosis is dependent on p53 in human lymphoid cells. Res Comm MoI Pathol Pharmacol 1999; 104: 285-92.
  • van Bree C, van der Maat B, Ceha HM, Franken NA, Haveman J, Bakker PJ. Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis. J Cancer Res Clin Oncol 1999; 125: 549-55.
  • Freeman ML, Borrelli MJ, Meredith MJ, Lepock JR. On the path to the heat shock response destabilization and formation of partially folded protein. Free Radical Biol Med 1999, 26: 737-45.
  • Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia Int J Hyperthermia 1995; 11: 459-88.
  • Mossser DD, Duchaine J, Massie B. The DNA-binding activity of the human heat shock transcription factor is regulated in vivo by hsp70. Molec Cell Biol 1993; 13: 5427-38.
  • Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993; 259: 1409-10.
  • Matsumoto H, Wang X, Ohnishi T. Binding between wild-type p53 and hsp72 accumulated after UV and ?-ray irradiatioa Cancer Lett 1995; 92: 127-33.
  • Oren M, Maltzman W, Levine AJ. Post-translational regulation of the 54K cellular tumor antigen and transformed cells. Molec Cell Biol 1981; 1: 101-10.
  • Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Molec Cell Biol 1983; 3: 2143-50.
  • Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54: 2287-91.
  • Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-10.
  • Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. In vivo adenovirus-mediatedp53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res 1996; 16: 3415-22.
  • Hupp TR, Sparks A, Lane DP. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 1995; 83: 237-45.
  • Brown CR, Hong-Brown LQ, Welch WJ. Correcting temperature-sensitive protein folding defects. J Clin Invest 1997; 99: 1432-44.
  • Ohnishi T, Ohnishi K, Wang X, Takahashi A, Okaichi K. Restoration of mutant TP53 to normal TP53 function by glycerol as a chemical chaperone. Radiat Res 1999; 151: 498-500.
  • Ohnishi T, Matsumoto H, Wang X, Takahashi A, Ohnishi K. Restoration of p53-dependent apoptosis in the cells bearing the mutant p53 gene by glycerol. Int J Radiat Biol 1999; 75: 1095-8.
  • Foster BA, Coffey HA, Morin MJ, Rastinejad F. Pharmacological rescue of mutant p53 conformation and function. Science 1999; 286: 2507-10.
  • Selivanova G, lotsova V, Okan I, Pritsche M, Strom M, Groner B, Grafstrom RC, Wiman KG. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nature Med 1997; 3: 632-8.
  • Ohnishi K, Ota I, Takahashi A, Ohnishi T. Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53. Br J Cancer 2000; 83: 1735-9.
  • Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Person DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KM, Putnam JB, Schea R, Shin DM, Walsh GL, Dolorment MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med 1996; 2: 985-91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.